Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 5/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.46 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.46 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | SLC18A3 | Q16572 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | GSR | P00390 | 2/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20995891 | 0.84 | CHRM2 (0.53) | CHRM2CHRM1CHRM4CHRM3KMT2A | |
| SCHEMBL789252 | 0.84 | CHRM2 (0.53) | CHRM2CHRM1CHRM4CHRM3KMT2A | |
| SCHEMBL7926056 | 0.79 | CHRM2 (0.48) | CHRM2CHRM1CHRM4CHRM3KMT2A | |
| SCHEMBL7920287 | 0.79 | CHRM2 (0.48) | CHRM2CHRM1CHRM4CHRM3KMT2A | |
| SCHEMBL7926060 | 0.79 | CHRM2 (0.48) | CHRM2CHRM1CHRM4CHRM3KMT2A | |
| SCHEMBL7549163 | 0.78 | — | — | |
| SCHEMBL7678513 | 0.77 | CHRM2 (0.48) | CHRM2CHRM1CHRM4CHRM3KMT2A | |
| SCHEMBL7678515 | 0.77 | CHRM2 (0.48) | CHRM2CHRM1CHRM4CHRM3KMT2A | |
| SCHEMBL27656244 | 0.77 | — | — | |
| SCHEMBL16672047 | 0.77 | CHRM2 (0.47) | CHRM2CHRM1CHRM4CHRM3KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6475955-B2 | HERBICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-11-05 | — | — | US | disclosed |
| US-20020026048-A1 | Pyridazinone derivatives | SUMITOMO CHEMICAL CO. LTD. | 2002-02-28 | — | — | US | disclosed |
| US-6187920-B1 | HERBICIDES | SUMITOMO CHEMICAL CO., LTD. (JP) | 2001-02-13 | — | — | US | disclosed |
| WO-2000021936-A1 | URACIL HERBICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2000-04-20 | — | — | WO | disclosed |
| EP-0947509-A2 | Pyridazinone derivatives | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-10-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020026048-A1 | Pyridazinone derivatives | PDXK, DDT, CBR3 | CHRM2 172/4885CHRM1 95/4885CHRM4 264/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.